HealthCare Global Enterprises will host an earnings conference call on Friday, August 7, 2026, at 2:00 PM IST to discuss its unaudited financial results for the quarter ended June 30, 2026 (Q1FY27). The event provides investors with a direct channel to senior management for insights into the company’s operational and financial performance during the period. This disclosure is made under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The Board of Directors of HealthCare Global Enterprises considered, approved, and took on record the standalone and consolidated financial results on Thursday, August 6, 2026. The subsequent call allows stakeholders to query management on key drivers behind the reported figures, including revenue trends, margin dynamics, and capital expenditure plans across its network of 25 hospitals in India and Africa.

Conference Call Details

The conference call will begin with a brief presentation by senior management outlining the Q1FY27 results. This will be followed by an interactive question-and-answer session. Participants can join via pre-registration to avoid wait times or through various international dial-in numbers.

Investors are advised to register in advance using the provided ExpressJoin link to connect without operator delay. The company emphasizes that this intimation is for record-keeping purposes as per exchange compliance requirements.

About HealthCare Global Enterprises

Headquartered in Bengaluru, HealthCare Global Enterprises operates under the brand "HCG" and positions itself as India’s largest cancer care provider. With a network spanning India and Africa, the company aims to deliver advanced diagnosis and treatment technologies under one roof. The firm continues to expand its footprint to bring specialized care to broader demographics.

Safe Harbor Statement

This document contains forward-looking statements based on management’s beliefs, opinions, and expectations as of the release date. These statements involve risks and uncertainties that are difficult to predict. Readers are cautioned against placing undue reliance on such projections, as the company does not assume any obligation to update them if circumstances change.

Healthcare Global Enterprises Ltd announced that its shareholders have approved the HCG Employee Stock Option Scheme 2026 and related resolutions through a remote e-voting process. The postal ballot, which concluded on July 08, 2026, sought approval for five special resolutions, including the grant of stock options to group company employees and the reappointment of key leadership personnel.

The scrutinizer's report, issued by Mr. V Sreedharan of V Sreedharan and Associates, confirmed that all five resolutions were passed with the requisite majority. The total number of valid votes polled across the resolutions was approximately 83.54% of the total paid-up equity capital. The resolutions included the approval of the ESOS 2026, the grant of options exceeding 1% of the issued share capital to a specific employee, and the reappointment of Mr. Rajiv Maliwal as an Independent Director.

Voting Results Summary

The following table details the voting outcomes for the key resolutions passed during the postal ballot:

Key Approvals

The reappointment of Mr. Rajiv Maliwal (DIN: 00869035) as an Independent Director received strong support, with 92.34% of the valid votes cast in favour. Additionally, shareholders approved the revision in remuneration for Dr. Manish Mattoo (DIN: 08431924), Executive Director and Chief Executive Officer of the Company. The voting was conducted exclusively through electronic means, with no physical postal ballots received.